2Yu YD,Park GC,Park P J,et al.Cytomegalovirus infectionassociated fulminant hepatitis in an immunocompetent adult requiring emergency living-donor liver transplantation:report of a case[J].Surg Today,2013,43:424-428.
3Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：829
4Omori K,Hasegawa K,Ogawa M,et al.Small-bowel hemorrhage caused by cytomegalovirus vasculitis following fulminant hepatitis.J Gastroenterol,2002,37:954-960.
5KunnoA,Abe M,Yamada M,et al.Clinical and histological features of cytomegalovirus hepatitis in previously healthy adults.Liver,1997,17:129-132.
6Miguelez M,Gonzalez A,Perez F.Severe cytomegalovirus hepatitis in a pregnant woman treated with ganciclovir.Scand J Infect Dis,1998,30:304-305.
7Serna-Higuera C,Gonzalez-Garcia M,Milicua JM,et al.Acute cholestatic hepatitis by cytomegalovirus in an immunocompetent patient resolved with ganciclovir.J Clin Gastroenterol,1999,29:276-277.
8Almeida — Porada GD,Ascensao JL. Cytomalovirus as a cause of pan-cytopenia[J]. Leuk Lymphoma, 1996,21:217 — 223.
6Gabardi S, Asipenko N, Fleming J, et ai. Evaluation of Low- versus High-Dose valganciclovir for prevention of cytomegalovirus disease in High-Risk renal transplant re- cipients[J]. Transplantation, 2015,99(7) : 1499-1505.
7Ferndndez-Ruiz M,Kumar D, Humar A. Clinical immune- monitoring strategies for predicting infection risk in solid organ transplantation[J]. Clin Transl Immunology, 2014, 3(2) : e12.
9Kotton CN,Kumar D,Caliendo AM, et al. Updated inter- national consensus guidelines on the management of cyto- megalovirus in solid-organ transplantation[J]. Transplan- tation,2010,89(7) :779-795.
